Logo image
Sign in
Imaging and Fluid Biomarkers of Disability Progression During 2 Years of Ocrelizumab Treatment in Black/African American and Hispanic/Latino People with Multiple Sclerosis (MS) in CHIMES (S3.004)
Journal article   Peer reviewed

Imaging and Fluid Biomarkers of Disability Progression During 2 Years of Ocrelizumab Treatment in Black/African American and Hispanic/Latino People with Multiple Sclerosis (MS) in CHIMES (S3.004)

Lilyana Amezcua, Nancy Monson, Mitzi Williams, Anthony Reder, Gregory Wu, Timothy Vartanian, Jinglan Pei, Christopher Harp, David Clayton, Ibraheem Abioye, …
Neurology, Vol.104(7_Supplement_1)
04/08/2025

Abstract

Abstract only

Metrics

1 Record Views

Details

Logo image